Vera Therapeutics Inc Class A (VERA)
R&D Expenses
$261.87M
TTM · Period ending: · USD
VERA R&D Expenses
Latest reported$261.87Mperiod ending
Latest reported$261.87Mperiod ending
VERA TTM R&D Expenses ($45.21M → $261.87M)
TTM R&D Expenses
High-resolution chart · PNG
VERA r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 261,874,000 | |
| 259,989,000 | |
| 215,256,000 | |
| 189,293,000 | |
| 173,134,000 | |
| 144,250,000 | |
| 127,641,000 | |
| 116,246,000 | |
| 92,032,000 | |
| 78,952,000 | |
| 79,897,000 | |
| 84,621,000 | |
| 88,177,000 | |
| 82,058,000 | |
| 68,993,000 | |
| 55,070,000 | |
| 38,978,000 | |
| 32,101,000 | |
| 22,484,000 | |
| 49,575,000 | |
| 47,980,000 | |
| 46,699,000 | |
| 45,206,000 |